A major discovery in cancer study is occurring with the use of nanobodies to re-engage mutated p53. This crucial cancer inhibitor protein is frequently disabled in many types of malignancies, leading uncontrolled body https://telebookmarks.com/story12598345/mini-antibodies-reactivate-the-p53-protein-a-potential-pathway-for-malignant-management